• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • China Cosmetics Quality and Safety Manager Qualification Requirements Eased by NMPA

China Cosmetics Quality and Safety Manager Qualification Requirements Eased by NMPA

china cosmetics quality and safety
Thursday, 26 May 2022 / Published in Cosmetics, News, NMPA Registration in China

China Cosmetics Quality and Safety Manager Qualification Requirements Eased by NMPA

China cosmetics quality and safety managers must be appointed to meet the requirements set by the Cosmetics Supervision and Administration Regulation (CSAR) for filing or registration of cosmetics.

On April 27, 2022, the NMPA (National Medical Products Administration) made a public announcement (No.224-2022) in response to the Jilin MPA and Chongqing MPA regarding the qualification requirements of the person in charge of cosmetics quality and safety in China.

Cosmetics registrants, Domestic Responsible Agents (DRA) and entrusted production enterprises must be equipped with a person in charge of quality and safety.

According to Article 32 of the CSAR, the person in charge of cosmetics quality and safety should possess:

  • professional knowledge in cosmetics safety and quality management; and
  • over 5 years of experience in cosmetics production or in the field of safety and quality management.

In the recent announcement, the NMPA further clarified that experience in the production of drugs, medical devices and special food products would be considered as equivalent to cosmetics only if the person applying for the role possesses and can demonstrate professional knowledge in cosmetics safety and quality management.

Note: Special food products include health food, formula for special medical purposes and infant formula, etc.

China Cosmetics Quality and Safety – NMPA Internal Guidelines

The provincial Medical Products Administration (MPA) departments are in charge of market supervision and the management of cosmetics. They are also responsible for checking if the registrants, filers, or quality and safety managers possess professional knowledge in cosmetics safety and quality management. The MPA departments must also verify whether the duties are performed to ensure product quality and safety meet the market standards.

On November 8, 2021, the NMPA published a Q&A article to respond to questions that were related to the requirements of appointing the person in charge of cosmetics quality and safety. Read our separate blog post where we cover more information in relation to the CSAR framework for cosmetics filing and registration in China.

As an NMPA Domestic Responsible Agent for cosmetics manufacturers and cosmetic ingredient suppliers worldwide, Cisema can assist you with ensuring that your company meets the latest product quality and safety requirements in China.

Cisema covers all your needs from domestic responsible agent to registration, from post-market compliance to in-China OEM and subsidiary localization.

Send us your enquiry to see how we can help you.

By Jeff Jiang.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers

What you can read next

China medical device industry standards march 2023 update
China medical device industry standards March 2023 update
Hainan Communication SOP
Hainan Communication SOP for Medical Device Clinical RWD Applications (Trial)
Clinical Trials GMP management
Clinical Trials GMP Management Specification for Drugs – Appendix (Draft) Issued

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP